EI
EVH icon

EAM Investors’s Evolent Health EVH Stock Holding History

EAM Investors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-80,287
Closed -$2.88M – 288
2022
Q3 		$2.88M Buy
80,287
+19,615
+32% +$691K 0.63% 36
2022
Q2 		$1.86M Sell
60,672
-36,088
-37% -$1.05M 0.45% 79
2022
Q1 		$3.13M Buy
96,760
+58,547
+153% +$1.53M 0.58% 38
2021
Q4 		$1.06M Sell
38,213
-25,996
-40% -$746K 0.17% 262
2021
Q3 		$1.99M Buy
+64,209
New +$1.54M 0.34% 116
2018
Q4 		– Sell
-117,063
Closed -$3.33M – 266
2018
Q3 		$3.33M Buy
+117,063
New +$2.79M 0.49% 77
2016
Q4 		– Sell
-31,704
Closed -$781K – 328
2016
Q3 		$781K Sell
31,704
-175,102
-85% -$4.09M 0.1% 278
2016
Q2 		$3.97M Buy
+206,806
New +$2.84M 0.6% 15

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

EAM Investors's EVH Position: Q4 2022 in Review

EAM Investors sold out of Evolent Health (EVH) in Q4 2022, closing a stake of 80,287 shares — an estimated $2.88M sold.

EAM Investors first reported a position in EVH in Q2 2016 and held it in 8 quarters. The position peaked at $3.97M in Q2 2016. 232 funds tracked by Wall St. Rank hold EVH as of Q4 2022.

  • EAM Investors reported no remaining Evolent Health position as of Q4 2022 after selling out during the quarter.
  • EAM Investors sold 80,287 Evolent Health shares in Q4 2022, an estimated $2.88M.
  • EAM Investors first reported a position in Evolent Health in Q2 2016 and held it in 8 quarters.
  • EAM Investors's Evolent Health position peaked at $3.97M in Q2 2016.
  • 232 funds tracked by Wall St. Rank held Evolent Health as of Q4 2022.

Based on EAM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.